Asset

Acetaminophen

Novartis AG Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (8)

NCT IDPhaseStatusStartCompletionSponsor nameTitle
NCT00489424phase4completed2007-06-012007-12-01Novartis PharmaceuticalsAcetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone Mass
NCT00428909phase1completed2006-11-012008-08-01Novartis PharmaceuticalsEffect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
NCT01973205phase3completed2013-10-012014-07-01NovartisEfficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
NCT01248468phase4completed2010-11-012011-03-01NovartisEfficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine
NCT01448057phase3completed2013-07-012015-08-01NovartisEvaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu

FDA applications (1)

ApplicationTypeApplicant
NDA 021082NDANOVARTIS CONSUMER HEALTH INC

Marketed products (1)

  • TAVIST ALLERGY/SINUS/HEADACHE